Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 5 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//PSYCHOLOGY, EXPERIMENTAL | 1830502 |
| 517 | 3 | BENZODIAZEPINES//GABAA RECEPTOR//ZOLPIDEM | 21456 |
| 645 | 2 | BENZODIAZEPINES//GABAA RECEPTOR//ZOLPIDEM | 13947 |
| 26992 | 1 | N DESMETHYLADINAZOLAM//ADINAZOLAM//SIDE EFFECTS DRUG | 260 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | N DESMETHYLADINAZOLAM | authKW | 484873 | 2% | 100% | 4 |
| 2 | ADINAZOLAM | authKW | 311697 | 2% | 43% | 6 |
| 3 | SIDE EFFECTS DRUG | authKW | 161623 | 1% | 67% | 2 |
| 4 | ADINAZOLAM DERACYN R | authKW | 121218 | 0% | 100% | 1 |
| 5 | ADINAZOLAM SR | authKW | 121218 | 0% | 100% | 1 |
| 6 | ALPROZOLAM | authKW | 121218 | 0% | 100% | 1 |
| 7 | ANTIDEPRESSANT ANXIOLYTIC COMBINATION | authKW | 121218 | 0% | 100% | 1 |
| 8 | ASAHIGAOKA | address | 121218 | 0% | 100% | 1 |
| 9 | CGI SEVERITY INDEX | authKW | 121218 | 0% | 100% | 1 |
| 10 | CLASSICAL BENZODIAZEPINES | authKW | 121218 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Psychiatry | 4890 | 49% | 0% | 128 |
| 2 | Pharmacology & Pharmacy | 2151 | 53% | 0% | 137 |
| 3 | Psychology, Clinical | 520 | 10% | 0% | 27 |
| 4 | Clinical Neurology | 154 | 12% | 0% | 31 |
| 5 | Neurosciences | 96 | 13% | 0% | 35 |
| 6 | Psychology | 77 | 4% | 0% | 11 |
| 7 | Chemistry, Medicinal | 44 | 5% | 0% | 12 |
| 8 | Medicine, Research & Experimental | 27 | 5% | 0% | 13 |
| 9 | Medicine, General & Internal | 16 | 5% | 0% | 14 |
| 10 | Behavioral Sciences | 11 | 2% | 0% | 5 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | ASAHIGAOKA | 121218 | 0% | 100% | 1 |
| 2 | DREP S PREVENT MED | 121218 | 0% | 100% | 1 |
| 3 | EXTRACORPORAL DETOXICAT CLIN | 121218 | 0% | 100% | 1 |
| 4 | DEP S PREVENT MED | 83916 | 1% | 23% | 3 |
| 5 | MARC MBRS UNDER PROGRAM | 60608 | 0% | 50% | 1 |
| 6 | STANLEY INNOVAT TREATMENT BIPOLAR DISORDER | 30303 | 0% | 25% | 1 |
| 7 | BAYC T GERIATR | 20201 | 0% | 17% | 1 |
| 8 | DEP NEUROSCI | 20201 | 0% | 17% | 1 |
| 9 | IDIB SBIPOLAR DISORDERS PROGRAM | 12120 | 0% | 10% | 1 |
| 10 | MED NEUROPSYCHIAT | 3563 | 0% | 3% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 11204 | 6% | 1% | 16 |
| 2 | JOURNAL OF CLINICAL PSYCHIATRY | 8209 | 8% | 0% | 22 |
| 3 | PSYCHOPHARMACOLOGY BULLETIN | 6763 | 4% | 1% | 10 |
| 4 | GENETIC PSYCHOLOGY MONOGRAPHS | 4894 | 1% | 2% | 2 |
| 5 | ACTIVITAS NERVOSA SUPERIOR | 4553 | 2% | 1% | 6 |
| 6 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 2039 | 3% | 0% | 9 |
| 7 | INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 1621 | 2% | 0% | 5 |
| 8 | HOMEOSTASIS IN HEALTH AND DISEASE | 1618 | 1% | 1% | 2 |
| 9 | PHARMATHERAPEUTICA | 1530 | 1% | 1% | 2 |
| 10 | INTERNATIONAL MEDICAL JOURNAL | 1397 | 1% | 1% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |